Neurology Market (By Type: Neurodegenerative Diseases, Neurovascular Diseases, Neuro-infectious Diseases, Others; By Procedure: Multiple Sclerosis, Epilepsy, Parkinsons Disease, Alzheimers Disease, Stroke, Others; By End User: Adult, Pediatric; By Application: Hospitals, Clinics, Diagnostic Centers, Research Institutes, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Neurology Market 

5.1. COVID-19 Landscape: Neurology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Neurology Market, By Type

8.1. Neurology Market, by Type, 2023-2032

8.1.1. Neurodegenerative Diseases

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Neurovascular Diseases

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Neuro-infectious Diseases

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Neurology Market, By Procedure

9.1. Neurology Market, by Procedure, 2023-2032

9.1.1. Multiple Sclerosis

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Epilepsy

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Parkinson's Disease

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Alzheimer's Disease

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Stroke

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Neurology Market, By End User 

10.1. Neurology Market, by End User, 2023-2032

10.1.1. Adult

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Pediatric

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Neurology Market, By Application 

11.1. Neurology Market, by Application, 2023-2032

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Clinics

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Diagnostic Centers

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Neurology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.1.3. Market Revenue and Forecast, by End User (2020-2032)

12.1.4. Market Revenue and Forecast, by Application (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.1.5.3. Market Revenue and Forecast, by End User (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Application (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.1.6.3. Market Revenue and Forecast, by End User (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Application (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.2.3. Market Revenue and Forecast, by End User (2020-2032)

12.2.4. Market Revenue and Forecast, by Application (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.2.5.3. Market Revenue and Forecast, by End User (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Application (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.2.6.3. Market Revenue and Forecast, by End User (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Application (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.2.7.3. Market Revenue and Forecast, by End User (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Application (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.2.8.3. Market Revenue and Forecast, by End User (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Application (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.3.3. Market Revenue and Forecast, by End User (2020-2032)

12.3.4. Market Revenue and Forecast, by Application (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.3.5.3. Market Revenue and Forecast, by End User (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Application (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.3.6.3. Market Revenue and Forecast, by End User (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Application (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.3.7.3. Market Revenue and Forecast, by End User (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Application (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.3.8.3. Market Revenue and Forecast, by End User (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Application (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.4.3. Market Revenue and Forecast, by End User (2020-2032)

12.4.4. Market Revenue and Forecast, by Application (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.4.5.3. Market Revenue and Forecast, by End User (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Application (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.4.6.3. Market Revenue and Forecast, by End User (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Application (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.4.7.3. Market Revenue and Forecast, by End User (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Application (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.4.8.3. Market Revenue and Forecast, by End User (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Application (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.5.3. Market Revenue and Forecast, by End User (2020-2032)

12.5.4. Market Revenue and Forecast, by Application (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.5.5.3. Market Revenue and Forecast, by End User (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Application (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Procedure (2020-2032)

12.5.6.3. Market Revenue and Forecast, by End User (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Application (2020-2032)

Chapter 13. Company Profiles

13.1. Siemens Healthineers AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. GE Healthcare

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Medtronic plc

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Philips Healthcare

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Johnson & Johnson

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Stryker Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Abbott Laboratories

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Boston Scientific Corporation

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. B. Braun Melsungen AG

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Carl Zeiss Meditec AG

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample